Tumor specific antigens (TSAs) are unique proteins or protein fragments that are exclusively expressed on the surface of cancer cells. These antigens arise as a result of genetic mutations, chromosomal rearrangements, or other alterations that are specific to the tumor cells. Unlike tumor-associated antigens (TAAs), which can also be found in normal cells but at different levels, TSAs are unique to cancer cells, making them important targets for cancer immunotherapy.
